Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.7250 (4%) ($15.7250 - $15.7250) on Fri. Sep. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.05% (three month average) | RSI | 81 | Latest Price | $15.7250(4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.5% a day on average for past five trading days. | Weekly Trend | ATRA advances 6.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(45%) ARKK(45%) IBB(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.525% in a week (0% probabilities). VIXM(-37%) VXX(-27%) IGOV(-16%) UNG(-13%) USO(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.525% (StdDev 3.05%) | Hourly BBV | 2.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $15.33(2.58%) | 10 Day Moving Average | $15.3(2.78%) | 20 Day Moving Average | $14.19(10.82%) | To recent high | -5.1% | To recent low | 31% | Market Cap | $1.168b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |